GLYCATION IN DIABETES AND AGING

Information

  • Research Project
  • 2791111
  • ApplicationId
    2791111
  • Core Project Number
    R01AG006943
  • Full Project Number
    3R01AG006943-10S1
  • Serial Number
    6943
  • FOA Number
  • Sub Project Id
  • Project Start Date
    2/1/1987 - 37 years ago
  • Project End Date
    8/31/1998 - 25 years ago
  • Program Officer Name
  • Budget Start Date
    5/15/1998 - 26 years ago
  • Budget End Date
    8/31/1998 - 25 years ago
  • Fiscal Year
    1998
  • Support Year
    10
  • Suffix
    S1
  • Award Notice Date
    11/30/1998 - 25 years ago

GLYCATION IN DIABETES AND AGING

DESCRIPTION (Adapted from Applicant's Abstract):Aging individuals succumb most frequently to vascular compromise, among various other complications. Diabetic patients suffer from a similar spectrum of problems, which, although mostly unrelated to insulin deficiency, have been clearly associated with hyperglycemia. The investigators have developed the central hypothesis that aging and diabetic complications are in part due to the covalent modification of tissue proteins by ambient glucose, forming time-stable adducts termed Advanced Glycosylation Endproducts (AGE). These irreversible reactive adducts increase linearly with age and at an accelerated rate in patients with diabetes. A macrophage receptor system specific for the removal of AGEs on senescent proteins and cells has been identified and characterized over the past 5 years. Ingestion and degradation of AGE-proteins by macrophages is followed by the synthesis of a host of cytokines and growth factors, suggesting a mechanism by which macrophages participate in tissue repair via this system. The AGE-receptor system appears to consist of two AGE-binding proteins, a 60 kD and a 90 kD, which have been purified and partially sequenced. Cellular aging and insulin excess have been identified as two important factors associated with a compromise in the efficiency of the macrophage receptors, possibly contributing to the acceleration of vascular dysfunction and hypertension associated with both aging and hyperinsulinemia. The objectives of the current proposal are: 1. To clone and sequence the genes of both AGE-receptor binding units, and to develop monoclonal antibodies, so as to proceed with the molecular and cell biology studies of the system, 2. To explore the regulation of expression and function of each AGE-binding protein at the mRNA and protein levels in response to various in vivo physiological and pathological states associated with Aging and Diabetes. 3. To study, the in vivo effects AGE accumulation in the vessels and kidney, two tissues which play a central role in the hypertension of diabetes and aging, using a novel AGE-animal model.

IC Name
NATIONAL INSTITUTE ON AGING
  • Activity
    R01
  • Administering IC
    AG
  • Application Type
    3
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    866
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    PTHA
  • Study Section Name
    Pathology A Study Section
  • Organization Name
    PICOWER INSTITUTE FOR MEDICAL RESEARCH
  • Organization Department
  • Organization DUNS
  • Organization City
    MANHASSET
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    11030
  • Organization District
    UNITED STATES